599 results on '"Chan, Anthony T. C."'
Search Results
2. Nasopharyngeal cancer screening with an anti-BNLF2b antibody: a new arrow in the quiver?
3. A novel tumor suppressor encoded by a 1p36.3 lncRNA functions as a phosphoinositide-binding protein repressing AKT phosphorylation/activation and promoting autophagy
4. Targeted Therapy and Immunotherapy for Nasopharyngeal Carcinoma
5. Author Correction: Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-κB activation and immune escape
6. Nasopharyngeal carcinoma: an evolving paradigm
7. Immunotherapy in Recurrent and Metastatic Nasopharyngeal Carcinoma
8. Early detection of nasopharyngeal carcinoma: performance of a short contrast-free screening magnetic resonance imaging
9. Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-κB activation and immune escape
10. Nasopharyngeal carcinoma
11. Nasopharyngeal cancer screening with an anti-BNLF2b antibody: a new arrow in the quiver?
12. Sequencing-based counting and size profiling of plasma Epstein–Barr virus DNA enhance population screening of nasopharyngeal carcinoma
13. Distinguishing early-stage nasopharyngeal carcinoma from benign hyperplasia using intravoxel incoherent motion diffusion-weighted MRI
14. The expanding universe of checkpoint inhibitors for nasopharyngeal cancer
15. Abstract PO-008: Association of plasma Epstein-Barr virus DNA and clinical response in patients with recurrent and/or metastatic nasopharyngeal cancer treated with pembrolizumab or standard-of-care chemotherapy in KEYNOTE-122
16. Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis
17. Fragmentation landscape of cell-free DNA revealed by deconvolutional analysis of end motifs
18. Nasopharyngeal carcinoma
19. Methylation analysis of plasma DNA informs etiologies of Epstein-Barr virus-associated diseases
20. Supplementary Figure S2 from Efficacy, Safety, and Pharmacokinetics of Axitinib in Nasopharyngeal Carcinoma: A Preclinical and Phase II Correlative Study
21. Supplementary Methods, Figures 1 - 3, Tables 1 - 2 from A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein–Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer
22. Frequency of Peripheral CD8+ T Cells Expressing Chemo-Attractant Receptors CCR1, 4 and 5 Increases in NPC Patients with EBV Clearance upon Radiotherapy
23. Recommendations for Epstein-Barr virus–based screening for nasopharyngeal cancer in high- and intermediate-risk regions
24. Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis
25. Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial
26. Nasopharyngeal carcinoma: relationship between invasion of the prevertebral space and distant metastases
27. The Evolving Role of Systemic Therapy in Nasopharyngeal Carcinoma: Current Strategies and Perspectives
28. Drug Therapy for Nasopharyngeal Carcinoma: Cytotoxic and Targeted Therapy
29. Preclinical evaluation of ribociclib and its synergistic effect in combination with alpelisib in non-keratinizing nasopharyngeal carcinoma
30. Viral co-infections and paraproteins in HIV: effect on development of hematological malignancies
31. Magnetic-field-modulated radiotherapy (MagMRT) in inhomogeneous medium and its potential applications
32. Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing
33. Retrospective study of the incidence and patterns of arterial and venous thrombosis in Chinese versus African American patients with multiple myeloma
34. Incorporating albumin–bilirubin grade into the cancer of the liver Italian program system for hepatocellular carcinoma
35. The effect of material assignment in nasal cavity on dose calculation for nasopharyngeal carcinoma (NPC) using Acuros XB
36. CpG methylation as epigenetic biomarkers for nasopharyngeal carcinoma diagnostics
37. Epigenetic Silencing of a Ca²⁺-Regulated Ras GTPase-Activating Protein RASAL Defines a New Mechanism of Ras Activation in Human Cancers
38. Shift detection discrepancy between ExacTrac Dynamic system and cone‐beam computed tomography
39. Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting β-catenin and AKT signaling but frequently methylated in common carcinomas
40. Prospective Randomized Phase II Study of Stereotactic Body Radiotherapy (SBRT) vs. Conventional Fractionated Radiotherapy (CFRT) for Chinese Patients with Early-Stage Localized Prostate Cancer
41. Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinoma
42. Clinical utility of plasma Epstein-Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma
43. Preclinical evaluation of the PI3K-mTOR dual inhibitor PF-04691502 as a novel therapeutic drug in nasopharyngeal carcinoma
44. Preclinical evaluation of the AKT inhibitor MK-2206 in nasopharyngeal carcinoma cell lines
45. Preclinical evaluation of combined TKI-258 and RAD001 in hepatocellular carcinoma
46. Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell lines
47. Towards magnetic-field-modulated radiotherapy (MagMRT) with an MR-LINAC – a Monte Carlo study
48. Preclinical evaluation of sunitinib as single agent or in combination with chemotherapy in nasopharyngeal carcinoma
49. Prediction of outcome in cancer patients with febrile neutropenia: a prospective validation of the Multinational Association for Supportive Care in Cancer risk index in a Chinese population and comparison with the Talcott model and artificial neural network
50. The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell lines
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.